Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors
about
Bacteriophage T4 GenomeStructure and function of type II DNA topoisomerasesRepair of topoisomerase-mediated DNA damage in bacteriophage T4An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase.Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents.Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites.Position-specific effect of ribonucleotides on the cleavage activity of human topoisomerase II.In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites.CP-115,953 stimulates cytokine production by lymphocytes.Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage.Functional determinants of gate-DNA selection and cleavage by bacterial type II topoisomerases.Isolation and characterization of mAMSA-hypersensitive mutants. Cytotoxicity of Top2 covalent complexes containing DNA single strand breaks
P2860
Q22061798-155A2870-7035-4C3B-A718-22821C26A772Q24528489-7B079D03-078C-48E9-A72F-E13CA78B8631Q28364144-99AD9720-7568-4118-8CF3-7E58953BD535Q33961513-57D052ED-10C1-4A5C-995C-6CC5E8F12483Q35890421-352E803C-70A2-4E73-9BC1-6E0AF91FA030Q35955209-250F90F8-BB96-4AA1-9A41-4678433D3A41Q36350970-685C5F95-BB19-4827-93DB-4E6FA4F13BDEQ36792820-0CD1A346-0FDB-4757-A794-87C4CA58834DQ39607594-1AF22345-BF1D-4E89-8388-67ECB6D3E554Q39718939-B3910C17-0CD4-4171-9EE5-8BAD92ED93F5Q39779184-1769E78D-0866-432D-88F5-A2C5AC9807C7Q40228760-09783D5E-2EA4-4B55-AB68-99C6835AE6C1Q41848451-8537C62D-8F31-4F18-ABCE-AF220B33F86CQ42114704-DF6BE098-CE6B-4B4B-A893-87BA32C79BFD
P2860
Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Mutational analysis of a type ...... ents for enzyme and inhibitors
@ast
Mutational analysis of a type ...... ents for enzyme and inhibitors
@en
Mutational analysis of a type ...... ents for enzyme and inhibitors
@nl
type
label
Mutational analysis of a type ...... ents for enzyme and inhibitors
@ast
Mutational analysis of a type ...... ents for enzyme and inhibitors
@en
Mutational analysis of a type ...... ents for enzyme and inhibitors
@nl
prefLabel
Mutational analysis of a type ...... ents for enzyme and inhibitors
@ast
Mutational analysis of a type ...... ents for enzyme and inhibitors
@en
Mutational analysis of a type ...... ents for enzyme and inhibitors
@nl
P2860
P1433
P1476
Mutational analysis of a type ...... ents for enzyme and inhibitors
@en
P2093
C H Freudenreich
K N Kreuzer
P2860
P304
P407
P577
1993-05-01T00:00:00Z